دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 12,000,000 تومان- قیمت ویژه : 6,250,000تومان
دسترسی ۳ ماهه به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 93 ﺭﻭﺯ
قیمت : 4,000,000 تومان- قیمت ویژه : 1,750,000تومان
Two Sides of a Coin: Safety Versus Harm of the ACC/AHA Perioperative Guideline Class 1 Level C-LD Recommendation for SGLT Discontinuation.
doi : 10.1161/CIRCULATIONAHA.125.072732
Volume 152(5) pgs. 287-348,e48-e62 August 05, 2025
Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 Trial.
Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation Receiving Oral Antiplatelet Therapy: Definitely Safe, but How Effective?.
Aortic Aneurysm Risk and the Somatic JAK2 V617F Mutation: Insights From a Multicenter, Population-Based Cardiovascular Screening Study.
Family Screening in Relatives at Risk for Plakophilin-2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy.
METTL3 Is Essential for Exercise Benefits in Diabetic Cardiomyopathy.
The Impact of Coronary Artery Disease in Patients With Peripheral Artery Disease Undergoing Lower-Extremity Revascularization for Chronic Limb-Threatening Ischemia.
Letter by Jha Regarding Article, "Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial".
Exercise Intolerance and Response to Training in Patients With Postacute Sequelae of SARS-CoV2 (Long COVID): A Scientific Statement From the American Heart Association.
